Inventor · disambiguated record
Peter-Colin Gregory
Also filed as: GREGORY PETER-COLIN
13 granted patents·17 pending applications·44 citations·filing 1990–2019
88Inventor score
Top patents by PatentIndex Score
30 records- 0187US8273348B2Lipase variants for pharmaceutical useSVENDSEN ALLAN·Filed 2007·Granted Sep 25, 2012·10 cites·25 claims
- 0279US9539311B2Lipase variants for pharmaceutical useNOVOZYMES AS·Filed 2015·Granted Jan 10, 2017·2 cites·19 claims
- 0376US7763607B2Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulatorsSOLVAY PHARM GMBH·Filed 2007·Granted Jul 27, 2010·1 cites·17 claims
- 0471US7074822B2Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2005·Granted Jul 11, 2006·2 cites·10 claims
- 0568US8802087B2Pharmaceutical compositions of lipase-containing products, in particular of pancreationSHLIEOUT GEORGE·Filed 2005·Granted Aug 12, 2014·2 cites·43 claims
- 0661US8058264B2Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditionsFIRNGES MICHAEL·Filed 2005·Granted Nov 15, 2011·1 cites·25 claims
- 0758US2009104126A1Sulfamate Compounds and Uses ThereofSOLVAY PHARM GMBH·Filed 2008·Application pending·0 cites
- 0857US9029115B2Lipase variants for pharmaceutical useSVENDSEN ALLAN·Filed 2012·Granted May 12, 2015·0 cites·20 claims
- 0956US8455235B2Protease variants for pharmaceutical useSVENDSEN ALLAN·Filed 2008·Granted Jun 4, 2013·0 cites·17 claims
- 1056US2008317726A1Proteases for Pharmaceutical UseNOVOZYMES AS·Filed 2006·Application pending·0 cites
- 1155US5010076A1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl)amidesKALI CHEMIE PHARMA GMBH·Filed 1990·Granted Apr 23, 1991·12 cites·10 claims
- 1255US2005124660A1Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compoundsFiled 2004·Application pending·0 cites
- 1354US6930207B2Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatmentSOLVAY PHARMACEUTICAL GMBH·Filed 2004·Granted Aug 16, 2005·2 cites·31 claims
- 1454US2007254863A1Use of CBx cannabinoid receptor modulators as potassium channel modulatorsANTEL JOCHEN·Filed 2007·Application pending·0 cites
- 1554US2005143441A1Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activityFiled 2004·Application pending·0 cites
- 1654US2005239859A2Novel medical uses of 4,5-dihydro-1h-pyrazole derivatives having cb1- antagonistic activitySOLVAY PHARM GMBH·Filed 2004·Application pending·0 cites
- 1751US5272143A6-oxoazepinoindole compounds, and pharmaceutical compositions containing themKALI CHEMIE PHARMA GMBH·Filed 1992·Granted Dec 21, 1993·12 cites·8 claims
- 1850US2011110910A1Proteases for Pharmaceutical UseNOVOZYMES AS·Filed 2011·Application pending·0 cites
- 1950US2011158976A1Enzymes for pharmaceutical useNOVOZYMES AS·Filed 2005·Application pending·0 cites
- 2049US2019275122A1Pharmaceutical compositions of lipase-containing products, in particular of pancreatinABBOTT PRODUCTS GMBH·Filed 2019·Application pending·0 cites
- 2149US2014302000A1Pharmaceutical compositions of lipase-containing products, in particular of pancreatinABBOTT PRODUCTS GMBH·Filed 2014·Application pending·0 cites
- 2248US2010135978A1Proteases for Pharmaceutical UseNOVOZYMES AS·Filed 2010·Application pending·0 cites
- 2347US2005261292A1Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditionsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 2447US2012207741A1Enzymes For Pharmaceutical UseSVENDSEN ALLAN·Filed 2012·Application pending·0 cites
- 2546US2004057944A1Microbial enzyme mixtures useful to treat digestive disordersSOLVAY PHARM GMBH·Filed 2003·Application pending·0 cites
- 2645US2005101585A1Use of selective CB1-antagonists in medical treatmentsSOLVAY PHARM GMBH·Filed 2004·Application pending·0 cites
- 2744US7772225B2N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditionsSOLVAY PHARM GMBH·Filed 2006·Granted Aug 10, 2010·0 cites·18 claims
- 2844US2009047266A1Lipases for Pharmaceutical UseNOVOZYMES AS·Filed 2006·Application pending·0 cites
- 2941US7547708B2N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereofSOLVAY PHARMACEUTICALS INC·Filed 2006·Granted Jun 16, 2009·0 cites·20 claims
- 3041US2007191357A1Methods of using potassium channel inhibiting compoundsANTEL JOCHEN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter-Colin Gregory files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →